KD033 clinical trials

A Phase 1, open-label, multiple-ascending dose study to investigate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of KD033 (SAR445710) in subjects with metastatic or locally advanced solid tumors

This study is testing a new medicine, KD033, for people with advanced cancer. It's a very early-stage trial focusing on how safe the medicine is, how it moves through the body, and if it shows any signs of working.